Mitos e Factos dos Anticorpos Monoclonais Biossimilares
With this article we intend to present facts and to expose several myths concerning the quality, safety and efficacy of therapeutic biosimilar monoclonal antibodies. We wish to summarize the experience of EMA regarding the biosimilar mAb and address the outstanding issues concerning the regulation a...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Formifarma, LDA.
2013-10-01
|
| Series: | Revista Portuguesa de Farmacoterapia |
| Subjects: | |
| Online Access: | http://revista.farmacoterapia.pt/index.php/rpf/article/view/40 |